Roche to acquire liver drug developer 89bio for up to $3.5 billion - Reuters
Roche to acquire liver drug developer 89bio for up to $3.5 billion Reuters
Roche to acquire liver drug developer 89bio for up to $3.5 billion Reuters
Roche to acquire liver drug developer 89bio for up to $3.5 billion Reuters
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.